Japan Animal Referral Medical Center Co., Ltd. logo

Japan Animal Referral Medical Center Co., Ltd. (6039)

Market Closed
12 Aug, 06:00
JPX JPX
¥
1,079. 00
+30
+2.8599%
¥
15.25B Market Cap
- P/E Ratio
32% Div Yield
64,600 Volume
- Eps
¥ 1,049
Previous Close
Add Transaction
Day Range
1,063 1,089
Year Range
536.8 1,605
Want to track 6039 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6039 closed today higher at ¥1,079, an increase of 2.8599% from yesterday's close, completing a monthly increase of 2.7619% or ¥29. Over the past 12 months, 6039 stock lost -8.5593%.
6039 is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Japan Animal Referral Medical Center Co., Ltd. has completed 1 stock splits, with the recent split occurring on Dec 15, 2025.
The company's stock is traded on one exchange.

6039 Chart

People also search for

Sakata Seed Corporation
¥ 4,395
0%
MTG Co., Ltd.
¥ 8,180
+2.7638%
As One Corporation
¥ 2,394.5
+0.5459%
Pigeon Corporation
¥ 2,082
0%
Noevir Holdings Co., Ltd.
¥ 4,840
+0.4149%

Japan Animal Referral Medical Center Co., Ltd. (6039) FAQ

What is the stock price today?

The current price is ¥1,079.00.

On which exchange is it traded?

Japan Animal Referral Medical Center Co., Ltd. is listed on JPX.

What is its stock symbol?

The ticker symbol is 6039.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 32%.

What is its market cap?

As of today, the market cap is 15.25B.

Has Japan Animal Referral Medical Center Co., Ltd. ever had a stock split?

Japan Animal Referral Medical Center Co., Ltd. had 1 splits and the recent split was on Dec 15, 2025.

Japan Animal Referral Medical Center Co., Ltd. Profile

Personal Care Products Industry
Consumer Staples Sector
Mr. Hidehiro Hirao CEO
JPX Exchange
JP3740000009 ISIN
Japan Country
294 Employees
- Last Dividend
15 Dec 2025 Last Split
- IPO Date

Overview

Japan Animal Referral Medical Center Co., Ltd. specializes in providing high-level healthcare services for animals, primarily dogs and cats, across Japan. Since its foundation in 2005, the company has set a benchmark in animal care by operating state-of-the-art medical centers. These facilities are equipped to offer comprehensive diagnostic and treatment services across a wide range of medical fields. Headquartered in Kawasaki, Japan, the organization has significantly contributed to elevating the standard of veterinary healthcare through its commitment to advanced medical practices and research in animal health.

Products and Services

The Japan Animal Referral Medical Center Co., Ltd. offers a broad spectrum of specialized care and services in various medical departments, including but not limited to:

  • Cardiology: Focused on diagnosing and treating heart conditions in pets.
  • Respiratory: Deals with the treatment of lung and airway disorders.
  • Urology: Specializes in diseases of the urinary tract systems.
  • Gastroenterology: Concerned with treating digestive system issues.
  • Oncology: Offers diagnosis and treatment for pet cancer.
  • Neurology: Treats disorders of the nervous system.
  • Orthopedics: Focuses on bone and joint issues.
  • Ophthalmology: Provides care for eye conditions.
  • Radiology and Imaging: Utilizes advanced imaging technology for diagnostics.
  • Anesthesiology: Ensures safe surgical practices and pain management.

Beyond these clinical services, the center is also involved in professional training for veterinarians and veterinary students, emphasizing clinical skills, treatment methods, and patient care. The dedication to research and development is evident in their involvement in pioneering projects, including genetic testing, immunotherapy, and regenerative medicine, aiming to advance the field of veterinary medicine further.

Contact Information

Address: 2-5-8 Kuji
Phone: 81 44 850 1320